文献速递关节外科

Medicare关节置换手术量趋势:2025至2040年预测

Trends in Medicare Arthroplasty Procedure Volume: Projecting From 2025 to 2040.
PubMed 文献 · J Arthroplasty · 2025-06-10

本研究回顾性分析了2013至2022年Medicare受益人初次和翻修全关节置换术(TJA)的手术量,并采用线性与泊松回归模型预测2025至2040年的趋势。结果显示初次全膝关节置换术(TKA)和全髋关节置换术(THA)手术量预计将持续增长,翻修THA手术量增长相对温和。

要点

  • 初次TKA年手术量从2013年603,704例增至2022年1,013,533例,预计2040年达2,793,919例。
  • 初次THA年手术量从2013年305,082例增至2022年594,981例,预计2040年达2,174,382例。
  • 翻修TKA年手术量从2013年53,446例增至2022年78,937例,预计2040年达227,515例。

核心结论

  • 初次TKA和THA的增长预计将持续并超过国家卫生支出。
  • 翻修THA手术量预计温和增长但低于初次THA,提示初次THA护理的改善可能降低了翻修率。
  • COVID疫情似乎未对TJA利用率产生持久影响。

研究设计与样本

  • 回顾性识别2013年至2022年由Centers for Medicare and Medicaid Services发布的数据。
  • 手术量根据Medicare Advantage参保情况进行调整。
  • 通过Current Procedural Terminology代码识别初次和翻修TJA患者。
  • 使用线性回归和泊松回归模型预测2025年至2040年的TJA手术量。
  • 使用历史数据和预测数据计算年增长率。

主要发现

  • 调整后初次TKA年手术量从2013年603,704例增至2022年1,013,533例,预计2040年达2,793,919例,2023至2040年年增长率为5.9%。
  • 初次THA年手术量从2013年305,082例增至2022年594,981例,预计2040年达2,174,382例,2023至2040年年增长率为7.6%。
  • 翻修TKA年手术量从2013年53,446例增至2022年78,937例,预计2040年达227,515例,2023至2040年年增长率为5.7%。
  • 翻修THA年手术量从2013年44,872例增至2022年49,471例,预计2040年增至67,620例,2023至2040年年增长率为1.6%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Characterizing and forecasting trends in total joint arthroplasty (TJA) utilization among Medicare beneficiaries has important implications for resource allocation. This study reports and predicts trends in primary and revision TJA among Medicare patients. METHODS: Patients were retrospectively identified from 2013 to 2022, which were published by the Centers for Medicare and Medicaid Services. Procedure volume was adjusted for Medicare Advantage enrollment. Primary and revision TJA patients were identified by Current Procedural Terminology codes. Linear and Poisson regression modeling was used to predict TJA volume from 2025 to 2040. Annual growth rates were calculated using historic and predicted data. RESULTS: The annual adjusted primary total knee arthroplasty (TKA) volume increased from 603,704 in 2013 to 1,013,533 in 2022 and is projected to reach 2,793,919 by 2040, with an annual growth rate of 5.9% from 2023 to 2040. Annual primary total hip arthroplasty (THA) volume increased from 305,082 in 2013 to 594,981 in 2022 and is projected to reach 2,174,382 by 2040 with an annual growth rate of 7.6% from 2023 to 2040. Revision TKA volume increased from 53,446 in 2013 to 78,937 in 2022 and is projected to reach 227,515 by 2040, with an annual growth rate of 5.7% from 2023 to 2040. Revision THA volume increased from 44,872 in 2013 to 49,471 in 2022 and is projected to increase to 67,620 by 2040, with an annual growth rate of 1.6% from 2023 to 2040. CONCLUSION: Growth in primary TKA and THA is expected to continue and outpace national health expenditure. Revision THA volume is expected to increase modestly but underperform primary THA, suggesting that improvements in primary THA care may be reducing revision rates. The COVID pandemic does not seem to have had lasting impacts on TJA utilization. LEVEL OF EVIDENCE: Therapeutic level III.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Jones CM, Potluri AS, Federico VP, et al. Trends in Medicare Arthroplasty Procedure Volume: Projecting From 2025 to 2040. J Arthroplasty. 2025. PMID: 40505750. doi:10.1016/j.arth.2025.05.124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。